Value proposition

Molecular diagnostics for infectious diseases and antibiotic resistance management.

Mobidiag is a biotechnology company specialized in development and commercialization of molecular diagnostics solutions used by clinical laboratories for detection of infectious diseases (gastrointestinal, respiratory and hospital-acquired infections) and antibiotic resistances (AMR).

Mobidiag offers 2 solutions:
- Amplidiag®, a multiplex qPCR-based product line comprising a large panel of diagnostic tests and the Amplidiag® Easy platform for automation of lab workflow. The Amplidiag® products are well suited for large laboratories with high-throughput screening (batch testing) requirements.

- Novodiag® is a fully automated molecular diagnostics solution for both syndromic and targeted testing of infectious diseases. Novodiag is particularly well suited for small to medium-sized laboratories as well as decentralized labs thanks to its ease of use and on-demand capacity.

As a result, combining both Amplidiag® and Novodiag® solutions, Mobidiag covers most of the microbiology laboratories requirements no matter their size, throughput and centralized/decentralized organization.

Follow us on LinkedIn, Twitter, Facebook for daily updates!

According to the latest GDPR requirements, visit our privacy policy page to learn more about how we collect your data and feel free to contact us if needed at marketing@mobidiag.com: http://mobidiag.com/assets/uploads/2018/05/mobidiag-privacy-policy.pdf

In Vitro Diagnostics (IVD), Infectious Diseases, Gastrointestinal infections, Gastroenteritis, Molecular Diagnostics, PCR, Assay Development, Platform Development, Medical Devices, Diagnostic Platforms, Diagnostics, IVD, Antibiotic resistance, Syndromic testing, Respiratory infections, COVID-19, AMR, Hospital-acquired infections, Sepsis, and Automation